Company Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company.
It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform.
The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.
The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms.
The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses.
The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally.
Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
| Country | Israel |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 142 |
| CEO | Ofer Haviv |
Contact Details
Address: 13 Gad Feinstein Street, Park Rehovot Rehovot, 7638517 Israel | |
| Phone | 972 8 931 1900 |
| Website | evogene.com |
Stock Details
| Ticker Symbol | EVGN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001574565 |
| CUSIP Number | M4119S104 |
| ISIN Number | IL0011050551 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Amit Noam Capt. res. | Chief Executive Officer of Lavie Bio Ltd. |
| Dr. Elran Hillel Haber M.B.A., Ph.D. | Chief Executive Officer of Biomica Ltd |
| Dr. Brian Ember | Chief Executive Officer of AgPlenus Ltd |
| Ofer Haviv CPA | Chief Executive Officer and President |
| Yaron Eldad | Chief Financial Officer |
| Mark Kapel | Chief Technology Officer |
| Rachel Pomerantz Gerber | Head of Investor Relations |
| Sassi Masliah | Vice President of Corporate Development |
| Liat Foigel Wejgman | Vice President of Human Resources |
| Eyal Ronen | Executive Vice President of Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 15, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Sep 30, 2024 | 424B3 | Prospectus |
| Sep 27, 2024 | EFFECT | Notice of Effectiveness |
| Sep 24, 2024 | UPLOAD | Filing |
| Sep 19, 2024 | F-1 | Registration statement for certain foreign private issuers |
| Sep 17, 2024 | 6-K | Report of foreign issuer |
| Sep 16, 2024 | 6-K | Report of foreign issuer |
| Sep 4, 2024 | D | Notice of Exempt Offering of Securities |
| Aug 26, 2024 | 424B5 | Filing |
| Aug 23, 2024 | 6-K | Report of foreign issuer |